Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018)
Xtant Medical Holdings' (XTNT) quarterly Restructuring Costs came in at $388000.0 in Q4 2018, down 79.21% year-over-year from $1.9 million in Q4 2017, and down 36.81% quarter-over-quarter from $614000.0 in Q3 2018.
Powered by 
Analysis
Xtant Medical Holdings (XTNT) Restructuring Costs (2017 - 2018) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Restructuring Costs for 2 consecutive years, with $388000.0 the latest figure, recorded in Q4 2018.
- On a quarterly basis, Restructuring Costs fell 79.21% year-over-year to $388000.0 in Q4 2018; TTM through Dec 2018 was $3.0 million, a 39.61% decrease from a year earlier, with the FY2018 full-year figure at $3.0 million, down 36.54% from the prior year.
- Restructuring Costs was $388000.0 for Q4 2018 at Xtant Medical Holdings, down from $614000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $1.9 million in Q4 2017 and troughed at $224000.0 in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 388,000.00 |
| Sep 30, 2018 | 614,000.00 |
| Jun 30, 2018 | 1.23 Mn |
| Mar 31, 2018 | 733,000.00 |
| Dec 31, 2017 | 1.87 Mn |
| Sep 30, 2017 | 1.19 Mn |
| Jun 30, 2017 | 1.63 Mn |
| Mar 31, 2017 | 224,000.00 |